- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02599051
Transobturator Verus Single Incision Slings
Transobturator Versus Single Incision Slings: 1 Year Results of a Randomized Control Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Transobturator slings are one type of sling that has become standard treatment for stress urinary incontinence. However, this procedure involves a total of 3 incisions to perform.
In contrast, single incision slings have been developed to treat stress urinary incontinence by using only one incision.
However, to date the success and complications of these two procedures have not been compared or studied.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with urodynamically proven stress urinary incontinence who were planning on undergoing surgery for treatment.
Exclusion Criteria:
- Patients with prior incontinence surgery, a urodynamic diagnosis of intrinsic sphincter deficiency and mixed incontinence with a predominance of detrusor overactivity were excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Monarc
Placement of a transobturator monarc sling for stress urinary incontinence
|
We will place a transobturator sling at the time of surgery for stress urinary incontinence
Other Names:
|
|
Experimental: Mini-arc
Placement of a single incision mini-arc sling for stress urinary incontinence
|
We will place a single incision sling at the time of surgery for stress urinary incontinence
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Objective Stress Urinary Incontinence
Time Frame: 1 year
|
The primary outcome was presence of leakage during cough stress test(CST) on examination
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life Questionnaire UDI-6
Time Frame: 1 year
|
Response to validated questionnaire: Urinary Distress Index(UDI-6) Measures symptoms on three subscales: 1. Irritative 2. Stress 3. Obstructive/Discomfort.
The mean value of all questions answered is then multiplied by 25 for the actual score (range 0 to 100) Summary score - Add the scores from the 3 scales together to obtain the summary score (range 0 to 300) The higher the score the greater the perceived impact that pelvic floor dysfunction has on a patient's life.
|
1 year
|
|
Subjective Patient Reported Recurrent or Persistent Stress Urinary Incontinence
Time Frame: 1 year
|
Assess if the patient has any complaint of stress urinary incontinence after surgery in follow up visits.
This will be history only, no examination.
|
1 year
|
|
Number of Participants Who Completed Self- Assessment of Cure
Time Frame: 1 year
|
Self-assessment of cure is based on 5 point scale, cured, greatly improved, somewhat improved, not improved, and worsened.
This is calculated by the number of patients that were analyzed.
|
1 year
|
|
Quality of Life Questionnaire IIQ-7
Time Frame: 1 year
|
Response to validated questionnaire: Incontinence Impact Questionnaire(IIQ-7) The IIQ measures the impact of urinary incontinence on activities roles, and emotional states.
A mean score is derived from each domain, then transferred to give weight to each subscale.
Subscale scores range from 0-100.
The total IIQ score is calculated by adding the four subscales score with a range of 0-400 possible.
A score closer to 0 represents activities not affected at all versus closer to 400 represent activities that were greatly affected.
|
1 year
|
|
Quality of Life Questionnaire ICIQ
Time Frame: 1 year
|
Response to validated questionnaire: International Consultation on Incontinence Questionnaire(ICIQ).
The ICIQ is a screening tool for incontinence.
The scoring scale is 0-21, minimum 0, maximum 21. a higher score indicates greater impairment from incontinence.
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: G Willy Davila, MD, Cleveland Clinic Florida
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB 9034
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Incontinence, Stress
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
University Magna GraeciaUnknownStress Urinary IncontinenceItaly
-
University of California, IrvineWithdrawnStress Urinary IncontinenceUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompleted
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Stress IncontinenceUnited States
-
GT Urological, LLCCompletedMale Stress Urinary IncontinenceAustralia, Czechia, New Zealand
-
Zekai Tahir Burak Women's Health Research and Education...CompletedFemale Urinary Stress IncontinenceTurkey
Clinical Trials on Monarc
-
The Cleveland ClinicAmerican Medical Systems; Good Samaritan Hospital, Ohio; Greater Baltimore Medical...CompletedStress Urinary IncontinenceUnited States
-
HealthCore-NERICompleted